Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03874234

Recruitment Status : Suspended (This study is on hold due to toxicity findings in a pre-clinical asset with the same mode of action as GSK'899. We are assessing the impact of these findings.)

First Posted : March 14, 2019

Last Update Posted : December 8, 2020

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Suspended
Estimated Primary Completion Date :	March 18, 2022
Estimated Study Completion Date :	March 18, 2022

To Top